Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
23 Dicembre 2024 - 10:30PM
Edgar (US Regulatory)
EXHIBIT
1
AGREEMENT
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of
1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with
respect to the ownership by each of the undersigned of shares of stock of Marker Therapeutics, Inc.
EXECUTED this 23rd day of December, 2024.
NEW
ENTERPRISE ASSOCIATES 16, L.P.
| By: | NEA
PARTNERS 16, L.P.
General
Partner |
| By: | NEA
16 GP, LLC
General
Partner |
By:
*
Anthony
A. Florence, Jr.
Managing
Partner and Co-Chief Executive Officer
By:
*
Mohamad
H. Makhzoumi
Managing
Partner and Co-Chief Executive Officer
NEA
PARTNERS 16, L.P.
| By: | NEA
16 GP, LLC
General Partner |
By:
*
Anthony
A. Florence, Jr.
Managing
Partner and Co-Chief Executive Officer
By:
*
Mohamad
H. Makhzoumi
Managing
Partner and Co-Chief Executive Officer
NEA
16 GP, LLC
By:
*
Anthony
A. Florence, Jr.
Managing
Partner and Co-Chief Executive Officer
By:
*
Mohamad
H. Makhzoumi
Managing
Partner and Co-Chief Executive Officer
*
Forest
Baskett
*
Ali Behbahani
*
Carmen Chang
*
Anthony A. Florence, Jr.
*
Mohamad H. Makhzoumi
*
Scott D. Sandell
*
Paul Walker
*/s/
Zachary Bambach
Zachary Bambach
As
attorney-in-fact
This Agreement relating to Schedule 13D was executed by Zachary Bambach
on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which is attached hereto as Exhibit 2.
EXHIBIT
2
POWER
OF ATTORNEY
KNOW
ALL MEN BY THESE PRESENTS, that the undersigned hereby constitutes and appoints Zachary Bambach, Nicole Hatcher and Stephanie Brecher,
and each of them, with full power to act without the others, his or her true and lawful attorney-in-fact, with full power of substitution,
to sign any and all instruments, certificates and documents that may be necessary, desirable or appropriate to be executed on behalf
of himself as an individual or in his or her capacity as a direct or indirect general partner, director, officer or manager of any partnership,
corporation or limited liability company, pursuant to section 13 or 16 of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), and any and all regulations promulgated thereunder, including, without limitation, Forms 3, 4 and 5 and Schedules 13D and
13G (and any amendments thereto), and to file the same, with all exhibits thereto, and any other documents in connection therewith, with
the Securities and Exchange Commission (the “SEC”), including, but not limited to, signing a Form ID for and on behalf of
the undersigned and filing such Form ID with the SEC, and with any other entity when and if such is mandated by the Exchange Act or by
the Financial Industry Regulatory Authority, granting unto said attorney-in-fact full power and authority to do and perform each and
every act and thing necessary, desirable or appropriate, fully to all intents and purposes as he or she might or could do in person,
thereby ratifying and confirming all that said attorney-in-fact, or his or her substitutes, may lawfully do or cause to be done by virtue
hereof. This power of attorney is perpetual, unless revoked by the undersigned in a signed writing delivered to each of the foregoing
attorneys-in-fact.
IN
WITNESS WHEREOF, this Power of Attorney has been signed as of the 29th day of February, 2024.
/s/
Peter J. Barris |
|
Peter
J. Barris |
|
|
|
/s/
Forest Baskett |
|
Forest
Baskett |
|
|
|
/s/
Ali Behbahani |
|
Ali
Behbahani |
|
|
|
/s/
Ronald D. Bernal |
|
Ronald
D. Bernal |
|
|
|
/s/
Ann Bordetsky |
|
Ann
Bordetsky |
|
|
|
/s/
Carmen Chang |
|
Carmen
Chang |
|
|
|
/s/
Philip Chopin |
|
Philip
Chopin |
|
|
|
/s/
Anthony A. Florence, Jr. |
|
Anthony
A. Florence, Jr. |
|
|
|
/s/
Jonathan Golden |
|
Jonathan
Golden |
|
|
|
/s/
Scott Gottlieb |
|
Scott
Gottlieb |
|
/s/
Mark Hawkins |
|
Mark
Hawkins |
|
|
|
/s/
Jeffrey R. Immelt |
|
Jeffrey
R. Immelt |
|
|
|
/s/
Aaron Jacobson |
|
Aaron
Jacobson |
|
|
|
/s/
Patrick J. Kerins |
|
Patrick
J. Kerins |
|
|
|
/s/
Hilarie Koplow-McAdams |
|
Hilarie
Koplow-McAdams |
|
|
|
/s/
Vanessa Larco |
|
Vanessa
Larco |
|
|
|
/s/
Julio C. Lopez |
|
Julio
C. Lopez |
|
|
|
/s/
Tiffany Le |
|
Tiffany
Le |
|
|
|
/s/
Mohamad H. Makhzoumi |
|
Mohamad
H. Makhzoumi |
|
|
|
/s/
Edward T. Mathers |
|
Edward
T. Mathers |
|
|
|
/s/
Gregory Papadopoulos |
|
Gregory
Papadopoulos |
|
|
|
/s/
Kavita Patel |
|
Kavita
Patel |
|
|
|
/s/
Scott D. Sandell |
|
Scott
D. Sandell |
|
|
|
/s/
A. Brooke Seawell |
|
A.
Brooke Seawell |
|
|
|
/s/
Peter Sonsini |
|
Peter
Sonsini |
|
|
|
/s/
Melissa Taunton |
|
Melissa
Taunton |
|
|
|
/s/
Paul E. Walker |
|
Paul
E. Walker |
|
|
|
/s/
Rick Yang |
|
Rick
Yang |
|
Grafico Azioni Marker Therapeutics (NASDAQ:MRKR)
Storico
Da Dic 2024 a Gen 2025
Grafico Azioni Marker Therapeutics (NASDAQ:MRKR)
Storico
Da Gen 2024 a Gen 2025